The type 1 receptor for insulin-like growth factors (IGF-IR), when activated by its ligands (IGF- I, IGF-II and insulin at supraphysiological concentrations) has at least 3 important biological activities; 1) it is mitogenic; 2) it regulates the establishment and maintenance of the transformed phenotype; and 3) it protects cells from apoptosis. This grant application focuses on the first two activities, which are partially overlapping, with greater emphasis on the transforming activity. Recent evidence from several laboratories have indicated that a functional IGF- IR plays a crucial role in transformation (colony formation in soft agar) and/or tumorigenesis. The basic observation was that mouse embryo cells with a targeted disruption of the IGF-IR genes are refractory to transformation by several oncogenes and other transforming agents. Conversely, a decrease in the number of IGF-IRs reverses the transformed phenotype. The laboratory is exploring the mechanism by which the IGF- IR regulates the establishment and maintenance of the transformed phenotype, with the long term goal of identifying the signaling pathways involved. In order to eventually reach that goal, the present application deals with the domains of the IGF-IR and with its immediate substrates that are required for the transforming signal. While the ras pathway is certainly involved in the transforming process, recent evidence indicates that other, ras-independent pathways must also be activated. The experiments are designed to define the receptor domains required for transformation, the role of IRS-1 (especially in relation to the SV40 T antigen), and the cloning of substrates specifically interacting with the transforming domains of the IGF-1R. Although the proposed project focuses on the IGF-1R, the information that would be generated could be extremely valuable in understanding the pathways of transformation in other systems as well, and the quasi-unique possibility of separating the pathway of transformation from the pathway of mitogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA053484-10
Application #
2882371
Study Section
Pathology B Study Section (PTHB)
Program Officer
Spalholz, Barbara A
Project Start
1990-12-01
Project End
2001-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Dews, M; Prisco, M; Peruzzi, F et al. (2000) Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases. Endocrinology 141:1289-300
Reiss, K; Wang, J Y; Romano, G et al. (2000) IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation. Oncogene 19:2687-94
Baffa, R; Reiss, K; El-Gabry, E A et al. (2000) Low serum insulin-like growth factor 1 (IGF-1): a significant association with prostate cancer. Tech Urol 6:236-9
Gatzka, M; Prisco, M; Baserga, R (2000) Stabilization of the Ras oncoprotein by the insulin-like growth factor 1 receptor during anchorage-independent growth. Cancer Res 60:4222-30
Morrione, A; Plant, P; Valentinis, B et al. (1999) mGrb10 interacts with Nedd4. J Biol Chem 274:24094-9
Romano, G; Prisco, M; Zanocco-Marani, T et al. (1999) Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling. J Cell Biochem 72:294-310
Valentinis, B; Morrione, A; Peruzzi, F et al. (1999) Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion. Oncogene 18:1827-36
Baserga, R (1999) The IGF-I receptor in cancer research. Exp Cell Res 253:1-6
Zanocco-Marani, T; Bateman, A; Romano, G et al. (1999) Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Res 59:5331-40
Valentinis, B; Romano, G; Peruzzi, F et al. (1999) Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J Biol Chem 274:12423-30

Showing the most recent 10 out of 46 publications